Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $123.24 | $24.47 | 403.61% | 232.53x | 211.24x | 15.63x | 18.88x | 1.80x | $106.92M | 0.82% | $705.78M | 6.70 | $13.22B | 1,685.20 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $236.01 | $94.34 | 150.16% | 38.69x | 32.58x | 6.56x | 23.32x | 1.18x | $793.95M | 2.52% | $1.35B | 10.14 | $32.86B | 27.86 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $24.78 | $8.28 | 199.21% | 118.00x | 154.01x | 6.97x | 14.12x | 1.09x | $39.15M | 1.21% | $220.58M | 1.69 | $3.19B | 70.37 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $79.38 | $16.38 | 384.69% | 74.19x | 63.05x | 7.32x | 9.47x | 2.30x | $182.84M | 2.97% | $654.15M | 8.43 | $6.03B | 50.24 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $65.07 | $21.17 | 207.30% | 171.24x | 17.52x | 3.69x | 1.99x | 1.08x | $738.18M | 5.86% | $6.32B | 32.68 | $15.91B | 41.25 | ||
| HALO | HALOZYME THERAPEUTICS INC | $108.64 | $70.68 | 53.71% | 30.52x | 13.09x | 7.66x | 85.90x | 0.66x | $806.22M | 6.33% | $143.54M | 1.22 | $14.31B | 19.92 | ||
| RPRX | ROYALTY PHARMA PLC | $61.33 | $38.40 | 59.70% | 32.62x | 11.43x | 10.76x | 3.60x | 0.67x | $2.92B | 10.71% | $9.79B | 21.99 | $43.41B | 36.92 | ||
| ADMA | ADMA BIOLOGICS INC | $9.55 | $8.71 | 9.64% | 13.26x | 11.38x | 4.25x | 5.24x | 0.60x | $116.47M | 5.34% | $408.21M | 1.79 | $2.20B | 9.45 | ||
| VCEL | VERICEL CORP | $42.30 | $8.86 | 377.16% | 88.13x | 87.74x | 7.05x | 5.85x | 2.09x | $61.66M | 2.85% | $370.04M | 7.25 | $2.13B | 48.43 | ||
| KRYS | KRYSTAL BIOTECH INC | $341.72 | $86.12 | 296.81% | 41.32x | 44.81x | 22.91x | 7.44x | 2.43x | $257.78M | 2.55% | $1.36B | 46.03 | $9.70B | 41.56 | ||
| TGTX | TG THERAPEUTICS INC | $56.01 | $23.78 | 135.48% | 18.19x | 39.75x | 9.93x | 14.19x | 2.13x | $17.39M | 0.22% | $604.08M | 4.26 | $8.84B | 63.51 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.65 | $9.42 | 23.72% | 12.26x | 11.25x | 5.07x | 3.18x | 0.80x | $82.01M | 11.90% | $217.65M | 3.68 | $548.00M | 7.09 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.21 | $2.23 | 43.88% | 16.05x | 13.88x | 1.97x | 3.08x | 0.83x | $5.67M | 2.24% | $82.53M | 1.04 | $189.58M | 10.14 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.22 | $6.42 | -81.08% | 8.68x | -4.11x | 1.50x | 1.60x | 0.07x | $19.58M | 27.82% | $44.20M | 0.76 | $22.02M | 2.88 | ||
| EXEL | EXELIXIS INC | $54.55 | $28.32 | 92.59% | 16.58x | 16.95x | 5.62x | 7.33x | 1.46x | $1.17B | 8.57% | $1.84B | 7.35 | $13.40B | 12.32 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $280.18 | $93.13 | 200.86% | 27.82x | 30.32x | 19.35x | 5.77x | 2.09x | $130.62M | 2.32% | $967.52M | 48.22 | $5.71B | 20.47 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $547.59 | $156.54 | 249.81% | 31.60x | 28.32x | 11.04x | 6.85x | 2.50x | $3.80B | 2.73% | $20.25B | 79.81 | $134.63B | 24.46 | ||
| TECH | BIO-TECHNE CORP | $72.39 | $15.89 | 355.44% | 101.96x | 34.69x | 9.35x | 5.44x | 1.87x | $269.60M | 2.38% | $2.09B | 13.34 | $11.41B | 44.59 | ||
| MDXG | MIMEDX GROUP INC | $4.27 | $1.10 | 286.91% | 106.75x | -38.06x | 1.78x | 2.88x | 1.51x | $44.50M | 7.05% | $216.00M | 1.46 | $503.76M | 22.09 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $254.47 | $194.25 | 31.00% | 16.68x | 9.86x | 3.50x | 3.44x | 0.69x | $1.62B | 10.07% | $4.80B | 75.98 | $19.29B | 11.94 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.50 | $32.68 | 17.82% | 12.26x | 10.14x | 2.32x | 2.24x | 0.72x | $354.90M | 15.91% | $999.24M | 17.25 | $1.85B | 6.59 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $828.50 | $413.39 | 100.41% | 19.75x | 17.74x | 5.48x | 2.69x | 1.30x | $3.76B | 4.42% | $31.71B | 308.48 | $85.55B | 14.88 | ||
| UTHR | UNITED THERAPEUTICS CORP | $512.88 | $222.75 | 130.25% | 16.96x | 18.74x | 6.93x | 3.44x | 2.29x | $1.09B | 5.00% | $6.40B | 150.24 | $20.19B | 12.05 | ||
| INCY | INCYTE CORP | $127.98 | $59.96 | 113.46% | 15.76x | 16.84x | 4.41x | 4.09x | 2.11x | $1.92B | 7.49% | $6.34B | 31.66 | $21.99B | 10.63 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.